YD Bio Ltd
Research YD Bio Ltd (YDES) on Bullrun: market cap USD 171.41M. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerYDES
- ExchangeNASDAQ
- CountryTaiwan
- SectorHealthcare
- IndustryBiotechnology
- CurrencyUSD
- Market capUSD 171.41M
- Financial periodFY2025
- RevenueUSD 596.82K
- Revenue growth16.9%
- Net income-USD 8.31M
- Free cash flow-USD 8.04M
- Gross margin28.1%
Valuation Snapshot
latest market cap is USD 171.41M.
About YD Bio Ltd
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.
Frequently asked questions
What is YD Bio Ltd's market cap?
YD Bio Ltd's market capitalization is USD 171.41M.
What does YD Bio Ltd do?
YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan.